How Do We Know When a Lymph Node Dissection is Adequate?

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.18, Iss.9, 2011-09, pp. : 2419-2421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?

By Gerber Bernd

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 613-624

Springer Publishing Company

Access to resources Recommend Favorite

Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

By Galimberti Viviana

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

Selection of Primary Breast Cancer Patients for Adjuvant Endocrine Therapy – is Oestrogen Receptor Alone Adequate?

By Cheung K.L.

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite

Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy

By Noguchi Masakuni

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 155-157

Springer Publishing Company

Access to resources Recommend Favorite

How do we optimally use cetuximab in first-line treatment for metastatic colorectal cancer?

By Lindsay Colin R Roxburgh Patricia Graham Janet

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 825-829

Future Medicine

Access to resources Recommend Favorite